Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
A Multicomponent Support Program to Enhance Quality of Life in Chinese Cancer Patients and Survivors (MSP-CCS): Pilot Optimization Trial and Implementation Outcomes
1 other identifier
interventional
64
1 country
7
Brief Summary
The purpose of this study is to evaluate different combinations of cancer education sessions, counseling sessions, and peer support meetings developed for Chinese cancer patients and survivors. The researchers will look at whether the combinations are practical and effective, and how they impact participants' quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Feb 2026
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 27, 2026
CompletedFirst Submitted
Initial submission to the registry
March 2, 2026
CompletedFirst Posted
Study publicly available on registry
March 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2028
May 1, 2026
April 1, 2026
1.9 years
March 2, 2026
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Proportion of eligible participants who enroll in the trial.
2 years
Proportion of participants who complete treatment
Pproportion of assessments that are completed, with completion defined as submitting the 24-week assessment with a minimum of the FACT-G completed.
24 weeks
Study Arms (8)
1 - Cancer Education + Meaning-Centered Counseling + Peer Support + Enhanced Standard Care
EXPERIMENTALAll participants will also receive cancer information materials and resources. Cancer education sessions, will have 3 weekly sessions.Counseling sessions, will have 3 weekly sessions. Peer support meetings, will have 3 monthly meetings.
2 - Cancer Education + Meaning-Centered Counseling + Enhanced Standard Care
EXPERIMENTALAll participants will also receive cancer information materials and resources. Cancer education sessions, will have 3 weekly sessions.Counseling sessions, will have 3 weekly sessions.
3 - Cancer Education + Peer Support + Enhanced Standard Care
EXPERIMENTALAll participants will also receive cancer information materials and resources. Cancer education sessions, will have 3 weekly sessions. Peer support meetings, will have 3 monthly meetings.
4 - Cancer Education + Enhanced Standard Care
EXPERIMENTALAll participants will also receive cancer information materials and resources. Cancer education sessions, will have 3 weekly sessions.
5 - Meaning-Centered Counseling + Peer Support + Enhanced Standard Care
EXPERIMENTALAll participants will also receive cancer information materials and resources.Counseling sessions, will have 3 weekly sessions. Peer support meetings, will have 3 monthly meetings
6 - Meaning-Centered Counseling- + Enhanced Standard Care
EXPERIMENTALAll participants will also receive cancer information materials and resources. Counseling sessions, will have 3 weekly sessions.
7 - Peer Support + Enhanced Standard Care
EXPERIMENTALAll participants will also receive cancer information materials and resources. Peer support meetings, will have 3 monthly meetings
8 - Enhanced Standard Care
ACTIVE COMPARATORAll participants will also receive cancer information materials and resources.
Interventions
Cancer Education on side effects and their management, treatment options, advance care planning, and survivorship. Each session will last about 30-60 minutes and will be completed over the phone or by video call.
Peer support aims to increase social support for CCS to decrease cancer stigma, which has been associated with greater psychological distress, especially among less acculturated Chinese immigrant CCS. The meetings will include up to 6-8 Mandarin-speaking patients and survivors and will last about 90 minutes.
enhanced standard care ( written cancer information materials in Chinese and referral to counseling)
Meaning-centered counseling aims to activate culturally relevant meaning-focused coping strategies in Chinese-speaking patients and survivors (CCS). Each session will last about 45-60 minutes and will be completed over the phone or by video call.
Eligibility Criteria
You may qualify if:
- Diagnosed with cancer (any type/stage) (per EMR for MSK patients or self-report for external participants) within the last 5 years
- Age ≥ 18 years (per EMR for MSK patients or self-report for external participants)
- Self-Report Criteria:
- Of Chinese descent
- Speaks Mandarin "well" or "very well"
- Moderately low HRQOL (\<70 FACT-G score)4, 48
- Resides in New York or New Jersey
- Agrees to participate via telehealth (video or phone)
- Agrees to be audio-recorded
You may not qualify if:
- Self-Report Criteria:
- Per PI determination, requires a higher level of care for current passive or active suicidal ideation than current protocol is able to provide. If a participant receives a score of \> 0 on item 9 of the PHQ-9,5 they will be referred to study PI for further evaluation using the Columbia-Suicide Severity Rating Scale. They will be excluded from participation in this study if there is presence of suicidal risk, determined by affirmative response(s) on the Columbia-Suicide Severity Rating Scale (C-SSRS)
- Too ill to participate determined by the question: "Do you feel too ill to participate because of communication problems, uncontrollable pain, or other symptoms that prevent you from participating?"
- Cognitive impairment (Montreal Cognitive Assessment 5 Minute - telephone version with a score \< 12)
- Per consenting professional determination, unable to understand the informed consent procedure
- Participation in study #14-076: Adaptation of Individual Meaning-Centered Psychotherapy for Chinese immigrant cancer patients)
- Currently receiving/have received psychotherapy/counseling/peer support within the last 6 months (patients being treated solely with psychotropic medications will not be excluded if they are not receiving psychotherapy/counseling/peer support)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Memorial Sloan Kettering Cancer Centerlead
- American Cancer Society, Inc.collaborator
- Brooklyn College Cancer Centercollaborator
- Herald Cancer Associationcollaborator
Study Sites (7)
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, New Jersey, 07920, United States
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, New Jersey, 07748, United States
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, New Jersey, 07645, United States
Memorial Sloan Kettering Cancer Center Suffolk- Commack (All Protocol Activities)
Commack, New York, 11725, United States
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, New York, 10604, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065, United States
Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale, New York, 11553, United States
Related Links
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Florence Lui, PhD
Memorial Sloan Kettering Cancer Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2026
First Posted
March 6, 2026
Study Start
February 27, 2026
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
February 1, 2028
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.